vidarabine phosphate has been researched along with Brain Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crowley, J; Eyre, HJ; Guy, JT; Hynes, HE; Jaeckle, KA; Taylor, SA; Townsend, JJ; Vogel, FS | 1 |
Bigner, DD; Friedman, HS; Schold, SC | 1 |
Bogdahn, U; Dünisch, G; Löbering, HG; Martin, R; Mertens, HG; Weber, H; Zapf, J | 1 |
Brown, LD; Cascino, TL; Dinapoli, RP; Everson, LK; Marschke, RF; Morton, RF; O'Fallon, JR | 1 |
1 trial(s) available for vidarabine phosphate and Brain Neoplasms
Article | Year |
---|---|
Phase II evaluation of fludarabine phosphate in patients with central nervous system tumors. A Southwest Oncology Group trial.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Remission Induction; Vidarabine Phosphate | 1991 |
3 other study(ies) available for vidarabine phosphate and Brain Neoplasms
Article | Year |
---|---|
Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice.
Topics: Animals; Azacitidine; Brain Neoplasms; Cell Line; Cytarabine; Doxorubicin; Humans; Medulloblastoma; Melphalan; Mice; Mice, Nude; Mitoguazone; Neoplasm Transplantation; Nitrosourea Compounds; Skin Neoplasms; Vidarabine Phosphate | 1986 |
Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.
Topics: Adolescent; Aged; Arabinonucleotides; Brain Neoplasms; Carmustine; Cells, Cultured; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Kinetics; Male; Middle Aged; Neoplastic Stem Cells; Podophyllotoxin; RNA, Neoplasm; Teniposide; Vidarabine Phosphate | 1987 |
Evaluation of fludarabine phosphate in patients with recurrent glioma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Brain Neoplasms; Drug Administration Schedule; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Vidarabine Phosphate | 1988 |